December 8th, 2023
We have developed techniques for mapping the visual cortex function utilizing more of the visual field than is commonly used. This approach has the potential to enhance the evaluation of vision disorders and eye diseases.
This research focuses on providing a practical, cost-effective visual presentation system to evaluate changes in the visual cortex due to ophthalmic diseases. We provide a method to create a wide viewing angle, retina atopic map, using FMRI to assess the functional activity of the visual cortex. A current experimental challenge is that standard systems for presenting visual stimuli for FMRI only cover small area of the visual fields, and with the view partially obstructed by the head coil.
This protocol provides method for wide view and unobstructed stimuli that balances cost, efficacy, and precision. Our protocol provides an affordable, moderately wide view of up to a hundred degrees of the visual field. Compared to other techniques, it avoids distortions, additional costs for projector lenses or fiber optic bundles, and other complexities, such as the need for contact lenses.
Our findings can be used to expand the understanding of the visual cortex, enabling the mapping of peripheral and central regions via an affordable, wide view FMRI system. This could enhance the management of visual impairments in eye diseases such as glaucoma, which involves dysfunction of the visual system in the brain.
View the full transcript and gain access to thousands of scientific videos
This study presents a cost-effective visual presentation system to evaluate changes in the visual cortex associated with ophthalmic diseases. Utilizing FMRI techniques, the research aims to create a wide viewing angle, retina atopic map that enhances the assessment of vision disorders by covering larger areas of the visual field than traditional methods.
Wide-view retinotopic fMRI enables comprehensive functional mapping of both central and peripheral visual cortex, addressing a critical gap in early discovery and translational neuroscience for ophthalmic disease. By expanding the measurable visual field, this approach increases predictive confidence in assessing cortical changes linked to vision loss, supporting risk-adjusted portfolio decisions in neuro-ophthalmology R&D. The method's cost-effectiveness and scalability facilitate broader adoption across discovery and preclinical pipelines.
This wide-view fMRI method integrates into the discovery-to-preclinical continuum for neuro-ophthalmology, supporting both early hypothesis testing and translational biomarker development.